The QualityStocks Daily Friday, February 7th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (GLTC) +184.23%

StockMarketWatch (LPTH) +51.28%

BUYINS.NET (ASRT) +46.15%

The QualityStocks Daily Stock List

GBT Technologies, Inc. (GTCH)

Zacks, OTC.Watch, VentureLine, last10k, Wallet Investor, Investing.com, Investors Hangout, Simply Wall St, Stockhouse, InvestorsHub, Nasdaq, Stockwatch, Street Insider, Market Screener, Investor Ideas, GlobeNewswire, TipRanks, GuruFocus, and OTC Dynamics reported previously on GBT Technologies, Inc. (GTCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GBT Technologies, Inc. specializes in the development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies. A development-stage enterprise, it has a portfolio of Intellectual Property (IP) that, upon commercialization, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. The Company previously went by the name Gopher Protocol, Inc. It changed its name to GBT Technologies, Inc. in August of 2019. Established in 2009, GBT Technologies is headquartered in Santa Monica, California.

The Company’s system foresees the creation of a worldwide mesh network. The heart of the system will be its advanced microchip technology that can be installed in any mobile or fixed device globally. GBT Technologies envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing, and enhanced mobile features as an alternative to traditional carrier services.

GBT’s Core Technology is a pioneering new platform with products that will change the way people interact with technology and each other. The Platform Technology is named GopherInsight™. It uses “public” RF spectrum to facilitate a private network between enabled devices. Products that use GopherInsight™ can have network access without using traditional Bluetooth, Cellular or Satellite connectivity.

GBT Technologies’ patent application for its secured communication integrated microchip (IC), GopherInsight™, protects unique integrated circuit technology targeted to be installed on IoT/mobile devices. The GopherInsight™ IC uses its own private network and satellite communications-based protocol to connect with other GopherInsight™ ICs in other IoT/mobile devices worldwide. The design of the circuits and its associated systems are to be communication protocol-aware and able to self-adjust in real time.

This week, GBT Technologies announced it received an innovative opinion for its 3D microchip patent. The patent authority, which manages the international research report, stated that the claims are novel and non-obvious. A positive opinion is a professional examiner’s analysis of the patent’s claims. The Company's 3D microchip patent is protecting GBT's futuristic integrated circuit technology that introduces new systems and methods for IC manufacturing. The invention presents new die structure and orientation, especially designed for deep nanometer range.

GBT Technologies plans to use the 3D integrated circuit technology for advanced GPUs and CPUs, and especially for AI/machine learning ICs, because they require a massive amount of smart circuitry. In addition, this invention is targeted to enable larger IoT/Mobile chips that include additional units on board like memory, analog, as well as RF circuitry.

GBT Technologies, Inc. (GTCH), closed Friday's trading session at $0.16, even for the day, on 23,854 volume with 30 trades. The average volume for the last 3 months is 55,870 and the stock's 52-week low/high is $0.125/$93.00.

chart

Indus Holdings, Inc. (INDXF)

Street Insider, Penny Stock Hub, NIC Investors, Market Wire News, New Cannabis Ventures, Stockwatch, Investing.com, Dividend.com, mg Retailer, GlobeNewswire, Wallet Investor, PetaCrunch, Morningstar, CBD Gummies World, Stockhouse, News Scanner, and TradingView reported beforehand on Indus Holdings, Inc. (INDXF), we also highlight the Company, here at the QualityStocks Daily Newsletter.

Indus Holdings, Inc. is a vertically integrated cannabis company based in Salinas, California. It has advanced production capabilities, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. Hospitality veteran Mr. Robert Weakley founded the Company. Indus Holdings’ shares trade on OTC Markets Group’s OTCQX.

The Company’s leadership team comprises hospitality, culinary, law enforcement, technology, finance, sales, and marketing veterans. Indus’ dedication is to transparency, working within the regulations of a growing market, and creating partnerships with community, State, and industry leaders who share its vision. Indus is creating products that emphasize consumer safety while advancing changing perceptions of cannabis use.

Indus Distribution is a division of Indus Holdings, Inc. Indus Distribution is a leading distributor of cannabis products, servicing a broad portfolio of brands and licensed retailers.

Indus offers services supporting every step of the supply chain and also offers an extensive portfolio of award-winning brands. These brands include House Weed, The Original Pot Co., MOON, Acme, Beboe, Dixie Elixirs & Edibles, and Orchid Essentials.

Indus Holdings announced in May 2019 that it signed a definitive agreement to acquire the assets of W The Brand (W Vapes), a multi-state manufacturer and distributor of cannabis concentrates, cartridges, and disposable pens, in a cash and stock transaction. The transaction solidifies Indus’ position as a market leader and leading force in the cannabis industry through expansion of its operations beyond California into the cannabis-friendly States of Nevada and Oregon.

At the end of November 2019, Indus Holdings announced its financial results for fiscal Q3 ended September 30, 2019. Revenue generated was $10.1 million; 94 percent year-over-year growth. Revenue for the nine-month period ending September 30, 2019, was $26.2 million; 140 percent year-over-year growth.

Revenue split per segment for the three-month period ended September 30, 2019, was 42 percent of revenue generated from Owned brands, 40 percent from Agency, and 18 percent from Distributed brands. Revenue for the three segments grew 38 percent for Owned brands year over year, Agency brand revenues grew 354 percent, and Distributed brand revenues grew 47 percent versus the preceding year.

Indus Holdings, Inc. (INDXF), closed Friday's trading session at $0.37411, off by 6.4725%, on 12,050 volume with 6 trades. The average volume for the last 3 months is 16,318 and the stock's 52-week low/high is $0.355899989/$11.0968999.

chart

Potash America, Inc. (PTAM)

OTC Dynamics, Stock Target Advisor, Financial Content, Simply Wall St, OTC.Watch, Whale Wisdom, Wallet Investor, Stockopedia, Barchart, GuruFocus, Morningstar, TipRanks, Investing News, YCharts, 4-Traders, Nasdaq, Investors Hangout, Dividend Investor, Mining Feeds, Investing.com, InvestorsHub, and OTC Markets reported earlier on Potash America, Inc. (PTAM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Potash America, Inc. is a multi-stage investment group listed on the OTC Markets. The Company pursues compelling technology, product, as well as service opportunities in innovative, emerging, and growing markets. The Company was previously known as Adtomize, Inc. It changed its name to Potash America, Inc. in March of 2011. Formed in 2007, Potash America has its corporate headquarters in Boca Raton, Florida.

The Company partners with inventive entrepreneurs in venture and growth capital investments. Potash America’s investment vision continues to explore the Environmentally Responsible Mining & Exploration, Renewable Energy, Commercial Agriculture Farming, Cannabis/Hemp Development, Health & Wellness, and Green Technology sectors.

Potash America pursues a strategy named “high-fusion.” With this approach, high-risk/high-reward ventures are balanced by more traditionally stable companies. This establishes a more varied portfolio that enables the Company to invest in creative or unempirical entrepreneurships whose partnerships it otherwise could not pursue.

Potash America plays a part in its potential partners’ growth beyond initial capital investment. To provide consistent support to its portfolio companies, the Company pursues several avenues to help them realize their goals. It is able to play a part in their growth via locating and negotiating acquisitions, financial remodeling, negotiating key strategic agreements, and raising capital.

Key sectors of Potash America’s portfolio include socioeconomic/environmentally responsible mining & exploration, renewable energy, and commercial agriculture farming. In addition, key sectors of its portfolio include cannabis and hemp development, health & wellness, and green technology. At present, mining & exploration includes investment opportunities in surface mining (open pit, dredging, placer, strip, hydraulic and mountain top) and underground mining (drift, hard rock, shaft, and slope).

Pertaining to renewable energy, Potash America chiefly dedicates its investment opportunities to solar, wind, biomass, and hydroelectric energy. Nonetheless, the Company maintains an interest in geothermal, hydrogen, as well as fuel cells. Moreover, regarding health & wellness, Potash America is looking to partner with creative entrepreneurs advancing new products in the health & wellness space, offering capital investment and guidance.

Potash America, Inc. (PTAM), closed Friday's trading session at $0.006, off by 7.6923%, on 80,980 volume with 4 trades. The average volume for the last 3 months is 60,729 and the stock's 52-week low/high is $0.002499999/$0.075000002.

chart

Valeritas Holdings, Inc. (VLRX)

Zacks, OTC Markets, StocksBeat, Nasdaq Trader, MacroTrends, Proactive Investors, Infront Analytics, Investors Observer, AI Stock Finder, Last10k, Alpha Stock News, 4-Traders, Stocktwits, Stocks Equity, Stockwatch, and Stockhouse reported earlier on Valeritas Holdings, Inc. (VLRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Valeritas Holdings, Inc. is a medical technology company and the maker of the V-Go® Wearable Insulin Delivery device that utilizes its proprietary h-Patch™ technology. The Company’s focus is on improving health and simplifying life for people with diabetes through developing and commercializing inventive technologies. It sells V-Go® to third-party wholesalers and medical supply distributors. A commercial-stage medical technology enterprise, Valeritas Holdings is headquartered in Bridgewater, New Jersey. It operates its research and development (R&D) functions in Marlborough, Massachusetts.

The V-Go® Wearable Insulin Delivery device is Valeritas’ flagship product. V-Go® is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with Type 2 Diabetes. It is worn like a patch and it can eliminate the need for taking manifold daily shots. V-Go administers a continuous pre-set basal rate of insulin over 24 hours. In addition, V-Go provides discreet on-demand bolus dosing at mealtimes.

V-Go is the only basal-bolus insulin delivery device on the contemporary market expressly designed keeping in mind the needs of Type 2 Diabetes patients. V-Go is cleared for use in the United States and the European Union and is commercially available in the United States.

Valeritas Holdings is developing two next generation single-use disposable V-Go devices - V-Go PreFill™ and V-Go SIM™. V-Go PreFill™ will enable the Company to sell V-Go along with the insulin in one commercial product. It will feature a prefilled insulin cartridge that the patient can snap into the V-Go device eliminating the insulin-filling process.

V-Go SIM™ will feature one-way communication to smart devices by way of RF/Bluetooth technology. V-Go Link™ will provide real-time tracking information of basal and bolus dosing use. The Company’s h-Patch™ is a drug delivery technology. It can facilitate the simple and effective subcutaneous delivery of injectable medicines to patients across a wide variety of therapeutic areas. Valeritas’ V-Go is the first FDA-approved (Food and Drug Administration) product that utilizes the h-Patch™ technology.

This past December, Valeritas Holdings announced that positive data from its preclinical pharmacokinetic (PK) study of CBD (cannabidiol) subcutaneous infusion was presented as a late-breaking poster presentation on Sunday, December 8, 2019 at the American Epilepsy Society 2019 Annual Meeting in Baltimore, Maryland. Valeritas believes this study represents the first report of CBD isolate delivered through subcutaneous infusion in any preclinical model.

The poster presentation title is “Therapeutic Plasma Levels of Cannabinoid (CBD) in Dogs Delivered Via h-Patch™ Subcutaneous Infusion.” In this poster presentation, Valeritas showcased for the first time data from both 40mg and 76mg of CBD isolate delivered over 24 hours with the h-Patch™ technology. Both dosages demonstrated fast and robust absorption and distribution, followed by prolonged elimination with near steady-state levels still detectable 24 hours after completion of h-Patch™ infusion, or 48 hours in total.

Valeritas Holdings, Inc. (VLRX), closed Friday's trading session at $0.635, up 2.4194%, on 192,895 volume with 362 trades. The average volume for the last 3 months is 269,596 and the stock's 52-week low/high is $0.550000011/$11.394.

chart

CCUR Holdings, Inc. (CCUR)

Zacks, Stock News, Pitch Book, Whale Wisdom, Stocktwits, Vintage Value Investing, Last10k, Simply Wall St, InvestorsHub, Stocksholm, GuruFocus, Accesswire, Seeking Alpha, 4-Traders, YCharts, Stockhouse, ValueWalk, TipRanks, MarketWatch, The Street, and Stockwatch reported earlier on CCUR Holdings, Inc. (CCUR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CCUR Holdings, Inc. operates MCA and real estate business segments via its subsidiaries Recur Holdings, LLC and LM Capital Solutions, LLC. Additionally, the Company actively pursues other business opportunities to maximize the value of its assets through evaluation of additional operating businesses or assets for acquisition.

Established in 1966, CCUR Holdings has its head office in Duluth, Georgia. The Company lists on the OTC Markets’ OTCQB. It was previously known as Concurrent Computer Corporation. It changed its name to CCUR Holdings, Inc. in January of 2018.

CCUR operates through its subsidiary LM Capital Solutions, LLC, which identifies and places capital with originators of merchant cash advance (MCA) financings with established track records of MCA underwriting and servicing excellence. CCUR also operates through its subsidiary Recur Holdings, LLC, which conducts, holds, as well as manages real estate operations.

This week, CCUR Holdings reported Net Income Attributable to its Stockholders of $2,737,000, or $0.31 per share, for Q2 of Fiscal Year 2020. During the prior Fiscal Year period, CCUR reported a Net Loss of $1,530,000, or $0.17 per share.

Revenue for the quarter increased to $1,787,000 versus $370,000 during the previous Fiscal Year period. The Revenue increase is mainly because of Merchant Cash Advance (MCA) Revenue of $1,440,000 versus $185,000 in Q2 of Fiscal Year 2019. Revenue from Interest on Loans grew 88 percent to $347,000. Other Interest, Dividend and Investment Income for the period totaled $2,361,000 versus a Loss of $639,000 in the previous Fiscal Year Q2.

Mr. Wayne Barr, President and Chief Executive Officer of CCUR Holdings, said, "We had another strong quarter and have now generated net income for four consecutive quarters. Our initial MCA business segment strategy is now fully deployed, and I believe our marketing efforts and the organizational infrastructure are catalysts for building on our current success.”

CCUR Holdings, Inc. (CCUR), closed Friday's trading session at $4.50, off by 0.221729%, on 35,146 volume with 30 trades. The average volume for the last 3 months is 8,696 and the stock's 52-week low/high is $3.00/$5.00.

chart

Cellectar Biosciences, Inc. (CLRB)

Zacks, Stocktwits, Streetwise Reports, AnalystRatings, Morningstar, Market Chameleon, Stockhouse, InvestorsHub, Stock News, Barchart, Nasdaq, Street Insider, BioPharmCatalyst, Stockopedia, Proactive Investors, last10k, MacroTrends, Equities.com, Simply Wall St, and Investing.com reported earlier on Cellectar Biosciences, Inc. (CLRB), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Cellectar Biosciences, Inc. is a clinical stage biopharmaceutical company listed on the NasdaqGS. It focuses on the discovery, development, as well as commercialization of drugs for the treatment of cancer. The Company previously went by the name Novelos Therapeutics, Inc. It changed its name to Cellectar Biosciences, Inc. in February 2014. Established in 2002, Cellectar Biosciences has its corporate office in Florham Park, New Jersey.

The Company’s core goal is to take advantage of its proprietary phospholipid drug conjugates™ (PDCs™) delivery platform to develop PDCs that specifically target cancer cells to deliver improved efficacy and better safety on account of fewer off-target effects. Cellectar Biosciences states that the PDC™ platform possesses the potential for the discovery and development of the next generation of cancer-targeting treatments. Cellectar plans to develop PDCs independently and through research and development (R&D) collaborations.

The Company’s lead product candidate is CLR 131. This is a Phospholipid Drug Conjugate™ (PDC) providing targeted delivery of a cytotoxic (cell-killing) iodine 131 with Cellectar’s PLEs (phospholipid ether) across a broad array of hematologic and solid cancers. In addition, the Company’s pipeline includes a series of preclinical PDC programs delivering chemotherapeutic warheads with its PLEs.

At present, CLR 131 is undergoing evaluation in Phase 1 and Phase 2 clinical studies. It is a small-molecule, cancer-targeting PDC designed to deliver cytotoxic radiation directly and selectively to cancer cells and cancer stem cells.

CLR 131 was granted Orphan Drug designation for the treatment of multiple myeloma by both the U.S. and the European Commission. Additionally, it was granted U.S. Orphan Drug and Rare Pediatric Disease designations for the treatment of neuroblastoma, rhabdomyosarcoma, Ewing’s sarcoma and osteosarcoma.

In early January of this year, Cellectar Biosciences announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development granted Orphan Drug Designation (ODD) to CLR 131 in Lymphoplasmacytic Lymphoma (LPL). CLR 131 is currently in a Phase 2 clinical study in relapsed or refractory select B-cell lymphomas, including Lymphoplasmacytic Lymphoma (LPL).

In addition, in January, Cellectar Biosciences announced it appointed Dr. Igor Grachev as Chief Medical Officer. Dr. Grachev, M.D., Ph.D., brings almost 20 years of industry experience to Cellectar Biosciences, having led clinical development programs at multinational pharmaceutical and biotech organizations.

Cellectar Biosciences, Inc. (CLRB), closed Friday's trading session at $2.68, off by 1.4706%, on 81,182 volume with 335 trades. The average volume for the last 3 months is 121,816 and the stock's 52-week low/high is $1.03999996/$3.75.

chart

Kirkland's, Inc. (KIRK)

Proactive Investors, Zacks, Stocktwits, Nasdaq, Investors Observer, Street Insider, last10k, MacroTrends, Annual Reports, Equities.com, Simply Wall St, InvestorsHub, and Investing.com reported earlier on Kirkland's, Inc. (KIRK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kirkland's, Inc. operates as a specialty retailer of home décor in the U.S. At present, the Company operates 432 stores in 37 states and an e-Commerce enabled website, www.kirklands.com. It operates its stores under the Kirkland's, Kirkland's Home, Kirkland's Home Outlet, Kirkland's Outlet, and The Kirkland Collection names. Established in 1966 by Carl Kirkland, Kirkland’s is headquartered in Nashville, Tennessee. The Company lists on the NasdaqGS.

Kirkland’s stores offer a wide selection of distinctive merchandise. This includes accent rugs, candles, framed art, mirrors, lamps, picture frames, garden accessories, holiday décor, furniture, and artificial floral products. Its merchandise offerings also include ornamental wall décor, fragrance, decorative accessories, textiles, housewares, gifts, and outdoor living items. In addition, its stores offer seasonal merchandise. Kirkland’s has more than 14,000 products across its digital and retails channels.

Kirkland’s is focusing on improving growth and profitability. Along with executive changes, the Company is continuing to aggressively manage its operating and infrastructure costs. It has further reduced expenses at its corporate office. Moreover, it is planning to close 27 stores in early 2020, with the potential for more reductions in the store base later in 2020 as the Company moves ahead with its goals to right size the store base.

Kirkland’s strategic priorities include Merchandising; it upgraded the quality of its assortment and added the new product categories tabletop, rugs and bedding. Strategic priorities also include Omni-channel; it is working to elevate the online experience to boost top line sales growth, while improving overall profitability.

Furthermore, strategic priorities include Infrastructure; the Company has made progress working with landlords to achieve rent reductions across the store base, which are expected to lessen lease costs in 2020 and beyond. In addition, Kirkland’s strategic priorities include Capital. It ended Q3 2019 with roughly $4 million in cash and $25 million of borrowings on its $75 million revolving credit facility.

Kirkland's, Inc. (KIRK), closed Friday's trading session at $1.33, up 3.9062%, on 1,368,213 volume with 3,697 trades. The average volume for the last 3 months is 751,620 and the stock's 52-week low/high is $0.910000026/$11.7700004.

chart

Jacksam Corporation (JKSM)

Otc.watch, Stockopedia, Real Investment Advice, Stockwatch, Simply Wall St, Investors Hangout, Last10k, GlobeNewswire, TradingView, Investors Hub, and PR Newswire reported earlier on Jacksam Corporation (JKSM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Jacksam Corporation is a workflow automation company focused on developing machinery and equipment solutions for the cannabis and CBD (cannabidiol) industry. The OTCQB-listed, Company designs and markets proprietary automated vape, POD and cartridge filling/capping equipment for the cannabis industry. It serves the medical cannabis, hemp, and CBD segments of the e-cigarette and vaporizer markets with its oil vaporizer focused products. Jacksam has its corporate office in Rancho Santa Margarita, California.

Jacksam’s automated equipment is designed and built in the United States. It carries the only full UL certification in the U.S. Using Jacksam/Convectium's automated equipment, its customers boost output by up to 60 times over hand filling.

Jacksam/Convectium is centered on helping its customers automate their workflow and get custom branded products onto dispensary shelves quickly. Greater than 100 companies, including many dominant brands in the space, rely on Jacksam/Convectium for automation of their filling operations.

Jacksam has adopted an “open source” business model enabling the majority of cannabis and CBD oil producers to benefit from its filling and capping equipment. Jacksam (shifting away from a closed system approach) has made its vape, POD and cartridge trays and equipment compatible with components produced by most of the leading worldwide manufacturers.

Recently, TILT Holdings, Inc. (CSE:TILT) (OTCQB:TLLTF), a foundational technology cannabis platform consisting of assets to support brands globally, announced that its subsidiary Jupiter Research, LLC, and Convectium Jacksam Corporation (JKSM), signed a memorandum of understanding (MOU) to create an exclusive proprietary cartridge and POD pre-racking solution, enabling producers and extractors to scale to meet fast growing demand. The Ultimate Automation Solution includes pre-racked Jupiter CCell® cartridge trays and Convectium’s filling and capping machines. This allows cannabis and CBD producers and extractors to save time and money by way of automatic filling and capping. TILT services greater than 2,000 brands and cannabis retailers across 33 States in the U.S., and also in Canada, Israel, Mexico, South America and the European Union (EU).

Jacksam Corporation (JKSM), closed Friday's trading session at $0.232, up 54.6667%, on 5,075 volume with 5 trades. The average volume for the last 3 months is 2,811 and the stock's 52-week low/high is $0.150000005/$2.50.

chart

Emerald Organic Products, Inc. (EMOR)

Stock2Own, OTC Markets, Whale Wisdom, InvestorsHub, Stockopedia, Stockwatch, Stockhouse, Wallet Investor, and Morningstar reported previously on Emerald Organic Products, Inc. (EMOR), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Emerald Organic Products, Inc. is a company specializing in organic meats. This past January, it announced the successful completion of a definitive agreement for a Plan of Merger with Pura Vida Health, LLC. Pura Vida Health is a health and wellness company. Its dedication is to using CBD (cannabidiol) and other natural ingredients to assist people in living healthier lives. Emerald Organic Products lists on the OTC Markets. The Company has its corporate office in Eden Prairie, Minnesota.

Mr. Matt Dill, Chief Executive Officer and Executive Chairman of Pura Vida Health, said in January, “Becoming a public company is a key element of our growth strategy, and the completion of this reverse merger is a significant accomplishment for the Pura Vida group. We believe in the all-star team we put together, we have proven experts in Cannabis, Hemp, CBD. I am talking all phases: planting, farming, extracting, the whole way, fully vertical. Add a group of professionals with a track record of successful branding of products, hundreds of millions in sales, very exciting. Becoming a publicly traded company allows us the opportunity to position Pura Vida Health as a strong player in this explosive market.”

On April 12, 2019, the President of Pura Vida Health, LLC, Mr. Ian Parker, provided a Shareholder Update following the Merger with Emerald Organic Products, Inc. Mr. Parker stated, “Today marks a major milestone for the Pura Vida community of valued customers, employees, partners, and affiliates. Today our company becomes part of a publicly-traded company on the OTC markets as a result of our previously announced merger with Emerald Organic Products, Inc. (EMOR).”

He further stated, “Our vision has always been to apply modern science to natural ingredients in a way that assist people in living a healthier life. After much consideration from our Board of Directors, Strategic Advisors, and colleagues, the decision to merge Pura Vida with a public company was made as a way of facilitating that vision.”

Pura Vida Health will continue to expand its offerings in to wellness, recovery, sports and fitness, and animals. Pura Vida Health will continue to develop its lead high quality Premium CBD that has demonstrated positive health and wellness results.

Emerald Organic Products, Inc. (EMOR), closed Friday's trading session at $2.74, up 41.2371%, on 336 volume with 3 trades. The average volume for the last 3 months is 575 and the stock's 52-week low/high is $0.50999999/$6.50.

chart

Black Cactus Global, Inc. (BLGI)

StreetInsider, Insider Financial, The Street, 4-Traders, Morningstar, Stockopedia, Dividend Investor, PennyStockHub, Stockhouse, Simply Wall St, MarketNewsUpdates, Tip Ranks, Stockwolf, Barchart, InvestingNewsAlerts, Stock Press Daily, InvestorsHub, OTC Markets, and InvestorsHangout reported previously on Black Cactus Global, Inc. (BLGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Black Cactus Global, Inc. is a technology development business focusing on Blockchain, machine learning, cryptocurrency, and the Internet of Things (IoT). Its corporate mission is to pioneer the application of Blockchain and overlapping technologies to protect IP (Intellectual Property) and the security of data and financial transactions. The Company is developing Blockchain applications for FinTech, Healthcare, Media and Supply Chain employing smart contracts and machine learning. Black Cactus Global is based in Las Vegas, Nevada.

The Company’s strategic plan is to become the first totally integrated digital financial institution with Blockchain technology as its operating foundation. Black Cactus Global’s services include Blockchain Applications, Trading Exchange, KYC/AML Biometrics, Music Exchange, and Card Programs and Payment Systems.

In addition, its services include Crypto Currencies, Internet of Things (IoT), Smart Contracts, as well as FinTech & MedTech. Black Cactus Global specializes in worldwide development and consulting projects in its key development areas of FinTech, digital media, financial services, KYC, AML, cyber security, and healthcare.

Black Cactus Global announced in January of this year that it entered into an MOU (Memorandum of Understanding) with the majority shareholders in an Indian Technology firm to establish a subsidiary of the Company. With the MOU, Black Cactus Global will become the largest stakeholder of a global Technology company with offices in the ‘FinTech Valley’ Vizag Software Technology Park in Visakhapatnam, India, through which it will center on and advance the use of its innovative Blockchain based IP.

In May 2018, Black Cactus Global announced that it completed a share exchange agreement with the Blockchain development subsidiary, Black Cactus Global Technologies Pvt. Limited (BCG-TPL). The agreement calls for Black Cactus Global to own an initial 29 percent interest in BCG-TPL, which has already attained major milestones that will enable Black Cactus to scale-up development activities.

Regarding Healthcare, Black Cactus Global concentrates on creating opportunities for digital health economies via Blockchain with AI, IoT, and Machine Learning. Pertaining to Energy, the Company offers privatized network grid provision to isolate green energy from traditional energy sources and a chain code logic to manage energy distribution and estimation.

Black Cactus Global, Inc. (BLGI), closed Friday's trading session at $0.0099, up 39.4366%, on 15,233 volume with 5 trades. The average volume for the last 3 months is 77,094 and the stock's 52-week low/high is $0.004/$0.026499999.

chart

Maricann Group, Inc. (MRRCF)

Weed Newswire, OTC Markets, Barchart, NewCannabisVentures, Stockhouse, Investopedia, Insider Financial, YCharts, The Street, MarketWatch, 4-Traders, Marketwired, Investors Hub, and TradingView reported on Maricann Group, Inc. (MRRCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Maricann Group, Inc. produces and distributes marijuana for medical purposes. The Company offers dried marijuana, cannabis oil, and gums. In addition, it provides accessories. These includes vaporizers, grinders, and other paraphernalia. OTCQB-listed, Maricann Group has its head office in Burlington, Ontario, and Munich, Germany. The Company has production facilities in Langton, Ontario.

On September 24, 2018, Maricann Group announced that it intends to change its name to Wayland Group Corp. In the interim, it expects to start operating via its subsidiaries under the business name “Wayland Group”. In expectation of the proposed name change, the Company also announced that, effective September 25, 2018, its ticker symbol on the Canadian Securities Exchange will be “WAYL”.

The Company is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Maricann Group has federal licenses in Canada to cultivate, extract, formulate, and distribute cannabis.

In Langton, Ontario, Maricann operates a medicinal cannabis cultivation, extraction, and formulation and distribution business under federal license from the Government of Canada, and Dresden, Saxony, Germany. The Company’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. At present, the Company is undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, to support existing and future patient growth.

The Company’s Germany-based Ebersbach facility targets the significant European market with 820,000 sq. ft. of cultivation space and greater than 12,000 patients. Maricann has developed educational programming for patients and healthcare professionals. Through exclusive pharmacy agreements with approximately 20 percent of the nation’s pharmacies, Maricann is working to become a leading provider of cannabis at physical point-of-sale locations that patients trust.

One of Maricann Group’s acquisition’s is NanoLeaf Technologies. NanoLeaf is a biotechnology company. It has licensing rights to a number of globally patented technologies that provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.

Additionally, Maricann Group acquired Haxxon AG. The acquisition of Haxxon forms an important element of Maricann’s European expansion strategy. Maricann is now positioned to enter the Swiss market via Haxxon’s production of feminized high CBD cannabis plants.

Recently, Maricann (Wayland Group) announced that it will open its first retail location in Zurich, Switzerland in 2019. It will serve the market with high-quality cannabis products, which contain a maximum THC content of 1 percent. The opportunity comes on the heels of the Company’s strategic acquisition of Haxxon AG, granting Maricann (Wayland) the opportunity to take advantage of Haxxon’s production facilities in Regensdorf, Switzerland, and its production of feminized high CBD cannabis plants.

Maricann (Wayland Group) also recently announced that it entered into an agreement to supply Cannamedical Pharma GmbH, a licensed, privately owned importer and distributor of cannabis in Germany to more than 2,200 pharmacies, with a minimum of 9,000 kilograms of EU-GMP certified cannabis flowers over a three year term. The two companies have completed mandatory quality assurance and control audits. They have scheduled the first shipment in December of this year.

Maricann Group, Inc. (MRRCF), closed Friday's trading session at $0.014, up 41.4141%, on 565,429 volume with 31 trades. The average volume for the last 3 months is 449,135 and the stock's 52-week low/high is $0.000099999/$1.00.

chart

Spotlight Innovation, Inc. (STLT)

Penny Picks, Profitable Trader Authority, Damn Good Penny Picks, OTCtipReporter, Beacon Equity Research, SuperStockTips, InvestorSoup, PennyStockScholar, Journal Transcript, PennyStockLocks, StockRockandRoll, Elite Stock Alerts, Penny Stock Finder, Stock Preacher, Penny Stock Craze, Stock Commander, TopPennyStockMovers, Ceocast News, and Real Pennies reported on Spotlight Innovation, Inc. (STLT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Spotlight Innovation, Inc. advances technologies designed to address rare, emerging, and neglected diseases. The Company identifies and acquires rights to unique and proprietary platform technology candidates. Its emphasis is on cancer drugs and related treatment therapies, solutions for infectious disease, and other specialty and distinctive opportunities.

The Company’s subsidiaries include Celtic Biotech and Caretta Therapeutics, LLC. Spotlight Innovation is based in Urbandale, Iowa.

Spotlight Innovation’s mission is to considerably impact patient health through advancing new platform biotechnologies for cancer and infectious disease. Access to platform technology candidates’ is attained through its extensive relationships with numerous leading academic institutions and other sources. Spotlight provides value-added development capability and funding to expedite development progress.

The Company’s development pipeline includes product candidates for cancer, chronic pain, spinal muscular atrophy (SMA) and Zika virus infection. Spotlight works to acquire the rights, via acquisition, license, or otherwise, to innovative and proprietary Platform Technology Candidates. Additionally, it works to provide value-added development capability and funding to achieve fast IND approval to commence human clinicals for targeted Platform Technology Candidates.      

Spotlight Innovation has obtained from the Florida State University Research Foundation (FSURF) exclusive global rights to develop and commercialize certain compounds for the treatment of viral infections. This includes the Zika virus infection.

Spotlight Innovation subsidiary Caretta Therapeutics has its chronic pain relief product Venodol Roll-on. This product is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation.

Spotlight Innovation has started Part 2 of a Phase 1 Cancer Trial. Its subsidiary, Celtic Biotech, started Part 2 of its Phase I dose escalation safety study, Crotoxin in Patients with Advanced Cancer using an Intravenous Route of Administration. Contract Research Organization (CRO) ImmunoClin Ltd. is supervising the study conduct.

Spotlight Innovation has entered into a multi-year partnership agreement with Hip-Hope, Inc. (Des Moines, Iowa-based), an organization committed to using arts and culture to promote, advocate and support hope for at-risk youth wherever symptoms of hopelessness are widespread.

As part of this partnership, Spotlight Innovation is the title sponsor for Hip-Hope’s 2018 “#kidslivesmatter FUNraiser Challenge” to take place August 3, 2018, at the 7 Flags Event Center in Clive, Iowa. The annual event is a youth empowerment campaign. The design of it is to build kids’ character, physical health, as well as self-esteem.

Recently, Spotlight Innovation announced that Company research collaborator Professor Kevin Hodgetts was awarded a grant of $300,000 by the nonprofit organization Cure SMA for the project Pre-Clinical Development of LDN-5178 for the Treatment of SMA.

Spotlight Innovation holds an exclusive, worldwide development and commercialization license from Indiana University Innovation and Commercialization Office for LDN-5178 and a group of related compounds. This includes STL-182.

Spotlight Innovation, Inc. (STLT), closed Friday's trading session at $0.00806, up 106.6667%, on 126,500 volume with 6 trades. The average volume for the last 3 months is 9,074 and the stock's 52-week low/high is $0.0035/$0.034000001.

chart

The Bon-Ton Stores, Inc. (BONTQ)

Penny Stock Hub, Zacks, Stockopedia, Investor Place, Investing.com, Stockflare, 4-Traders, InvestorsHub, StreetInsider, YCharts, Barchart, Stockhouse, and TradingView reported on The Bon-Ton Stores, Inc. (BONTQ), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

Listed on the OTC Markets Group’s OTCQB and established in 1898, The Bon-Ton Stores, Inc. operates 250 stores. These include nine furniture galleries, in 23 states in the Northeast, Midwest and upper Great Plains under the Bon-Ton, Bergner's, Boston Store, Carson's, Elder-Beerman, Herberger's and Younkers nameplates. The Bon-Ton Stores has corporate headquarters in York, Pennsylvania and Milwaukee, Wisconsin.

The Company’s stores offer a wide variety of national and private brand fashion apparel and accessories for women, men and children. The stores also offer cosmetics and home furnishings.

The Bon-Ton Stores has been taking action over the past number of months to boost improved performance and strengthen its financial position. The Company has taken another step forward in its efforts through filing voluntary petitions for a court-supervised restructuring under Chapter 11.

On February 4, 2018, The Bon-Ton Stores, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Its varied stores throughout the U.S. are open. In addition, its e-commerce and mobile platforms are operating normally.

Recently, The Bon-Ton Stores announced that it received a signed letter of intent (LOI) from an investor group consisting of DW Partners, Namdar Realty Group (including its partner Mason Asset Management) and Washington Prime Group. This investor group proposes to acquire The Bon-Ton Stores as a going concern in a Bankruptcy Court-supervised sale process.

The Bon-Ton Stores and this investor group are in the process of finalizing an asset purchase agreement in advance of an auction. The auction is now scheduled to be held on Monday, April 16, 2018.

Mr. Bill Tracy, The Bon-Ton Stores’ President and Chief Executive Officer, said, "We are pleased to have received this signed letter of intent and are advancing our discussions with the investor group to complete an asset purchase agreement as we proceed toward the court-supervised auction. With the help of our advisors, we will evaluate all qualified bids and are committed to maximizing value and pursuing the best path forward for the Company and our stakeholders.”

The Bon-Ton Stores, Inc. (BONTQ), closed Friday's trading session at $0.012, up 50.00%, on 2,672 volume with 6 trades. The average volume for the last 3 months is 19,408 and the stock's 52-week low/high is $0.0003/$0.039999999.

chart

GelTech Solutions, Inc. (GLTC)

BullRally, InvestorPlace, CoolPennyStocks, HotOTC, SmallCapVoice, TheMicrocapNews, Investor Relations, OTC Picks, PennyTrader Publisher, Wise Alerts, CRWEFinance, and Stock Rich reported previously on GelTech Solutions, Inc. (GLTC), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

GelTech Solutions, Inc. is a leading provider of unique, environmentally friendly, and cost-effective products. These products help government agencies, industry, agriculture, and the public reach goals, including water conservation and protecting lives, homes and property from fires. GelTech is an innovator in the use of environmentally-friendly polymers for fire suppression and protection. The Company is based in Jupiter, Florida.

GelTech Solutions has its FireIce Wildland Fire Division. It specializes in providing innovative fire chemicals and equipment, and also industry-leading training and support, to wildland fire agencies globally.

GelTech Solutions’ products include Fire Suppression, Industrial Absorbents, and Soil Amendments. FireIce® is a firefighting product. FireIce is in use at manifold fire departments throughout the nation as a supplement to their fire suppression equipment. FireIce has been approved by the United States Forest Service for use on the ground and from the air to suppress oncoming wildland fires.

FireIce® is a non-toxic dry polymer. When mixed with water it becomes a very effective and versatile gel used by wildland and municipal firefighting agencies as a suppressant to extinguish fires and as a fire retardant to protect assets and property. Additionally, FireIce can suppress specifically challenging manhole, tire, magnesium and other fires more than 10,000 degrees Fahrenheit. It can also suppress electrical fires of up to 50,000 volts.

GelTech Solutions is working with a number of industrial clients that are incorporating FireIce Shield® into their manufacturing process. This is to prevent fires and avoid expensive business interruptions while processing flammable materials.

GelTech Solution’s Soil2O Dust Control and Soil Cap are cost effective, polymer-based products. The construction and mining industries, farmers and local communities use these products to reduce airborne particulate matter with minimal environmental impact.

Soil2O Topical and Soil2O Granular are a line of moisture retention products. They are used in agriculture, commercial landscaping and by homeowners to improve crop, plant, and lawn health while lessening water usage by up to 50 percent.

The Company also has its GT-W14. This is an advanced absorbency technology. It is used by manufacturers, shippers, and auto maintenance facilities to control industrial fluid spills of all sizes, turning liquids into solid waste for easier and safer disposal.

This past June, GelTech Solutions announced that the FireIce Wildland Fire Division secured two new geographically dispersed western state firefighting agencies for the evaluation of FireIce products in airtankers. The agencies are running pilot programs that include the evaluation of new state-of-the-art tanker base loading equipment. Furthermore, the FireIce Wildland Fire Division is supporting the Oregon Department of Forestry for the third straight season, and Saskatchewan Northern Air Operations and Washington Department of Natural Resources for the second season.

GelTech Solutions has launched its FireIce Lithium Battery Active Suppression Kit. It automatically detects elevated temperatures releasing FireIce ST, a special blend of FireIce, to the affected battery module, to cool and suppress the batteries and prevent the system from reaching runaway that could cause an explosion. The design of the kit is to deliver FireIce ST product only to the battery compartment where it is required, leaving other compartments untouched.

GelTech Solutions, Inc. (GLTC), closed Friday's trading session at $0.03425, up 184.2324%, on 3,661,700 volume with 342 trades. The average volume for the last 3 months is 102,614 and the stock's 52-week low/high is $0.010099999/$0.214849993.

chart

The QualityStocks Company Corner

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has issued 550,000 stock options to an insider of the Company for the purchase of up to 550,000 common shares of the Company at an exercise price of US$0.47 (the "Options"). The Options are being issued pursuant to the Company's shareholder approved Equity Incentive Plan and are exercisable for a period of five years without any vesting provisions.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Friday's trading session at $0.48208, up 3.6731%, on 14,951 volume with 25 trades. The average volume for the last 3 months is 104,570 and the stock's 52-week low/high is $0.3037/$1.57000005.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc.  (TSX: WLLW; OTCQB: CANSF) is pleased to announce that it has appointed Dr. Peter Seufer-Wasserthal as independent Chairman of the Board of Directors and Dr. Joseph Tucker as Chief Operating Officer of Willow. In conjunction with Dr. Seufer-Wasserthal's appointment, Dr. Tucker has resigned from the position of Executive Chairman and will remain on the Board of Directors.  Dr. Seufer-Wasserthal previously served as an independent Director of Willow. Also today, CBDWire released a report on the company detailing how the journey hasn’t been easy for hemp, and it might be a little rough before things get better. The crop had been outlawed for decades before the Farm Bill legalized it in December 2018. The legislation gave farmers leeway to grow the crop under state and tribal programs and within a year, hemp was worth millions in sales.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Friday's trading session at $0.55, even for the day, on 2,555 volume with 6 trades. The average volume for the last 3 months is 10,466 and the stock's 52-week low/high is $0.400999993/$2.1775.

Recent News

chart

Jerrick Media Holdings, Inc. (OTC: JMDA)

The QualityStocks Daily Newsletter would like to spotlight Jerrick Media Holdings, Inc. (OTC: JMDA).

In a mutually beneficial move for Vocal creators, brand partners and the Vocal platform itself, Jerrick Media Holdings Inc. (OTC: JMDA) recently released their latest revenue-generating feature, Challenges. Hosted on Vocal, Jerrick’s proprietary long form publishing platform, Challenges were introduced as themed story contests that inspire the creators and authentically engage with Vocal’s creators through crowdsourced native content creation (http://nnw.fm/8pcVl).

Jerrick Media Holdings, Inc. (OTC: JMDA) develops technology-based solutions to solve digital problems. Through the combination of design, thought and data analysis, the company builds products that influence a worldwide audience.

Jerrick’s flagship product is Vocal, a proprietary long-form digital publishing platform that provides storytelling tools and engaged communities for creators to get discovered and fund their creativity.

Vocal

Designed to develop and cost-effectively engage content creators, the Vocal platform enables its over 500,000 registered content creators to reach an engaged audience and monetize their content. In addition to providing relevant content, Vocal’s technology is centered on efficiency and scalability through its niche digital communities, as well as output through its data-driven distribution strategy.

Vocal partners with content creators and brands that recognize difficulties inherent in the digital advertising space and that can benefit from branded content marketing opportunities available on publishing platforms like Vocal.

All content available on Vocal is created within the platform’s custom editor and published on one of Vocal’s embedded genre-specific communities, spanning topics that range from food to wellness, beauty, technology and more.

In May 2019, Jerrick launched Vocal+, its premium subscription membership program. Vocal+ members pay a membership fee for premium value-added features, including receiving increased earnings for their content, reduced platform processing fees for tips received, a Vocal+ badge on their creator page, access to new features on the Vocal Platform, and other rewards. Creators can sign up for free or upgrade to Vocal+, available for purchase on either an annual or monthly subscription basis.

 

Vocal for Brands

Vocal for Brands is an in-house creative studio that generates actionable data from bespoke native advertising campaigns. Vocal for Brands partners with direct-to-consumer (DTC) to create beautiful, campaign-optimized stories on Vocal that build brand affinity, trust and drive results.

Additionally, Jerrick provides a Managed Services offering to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing and e-commerce solutions. Managed Services includes the setup and ongoing maintenance of clients’ websites, Amazon and Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by e-commerce sellers for sales and growth optimization. In addition to partnering with Managed Services clients, the company offers a range of la carte services.

Growth Strategy

Upon the consummation of its anticipated listing on the Nasdaq Capital Market, Jerrick intends to change its official company name to “Creatd, Inc.,” subject to stockholder approval.

This rebranding will initiate Jerrick’s go-forward growth strategy and its plans to expand its offerings and provide technology products and resources for creators to help transform their ideas into reality. The strategic plan is designed to greatly increase Jerrick’s potential market value via a plethora of new revenue streams.

Creatd will focus on a community of creators that number more than 2.5 billion users, for which it will offer democratized, transparent platforms for distribution, sentiment, resources and monetization. The company’s agile development process will rely on a combination of bleeding-edge technology that eliminates barriers and creates efficiencies. Superior design thinking and data analysis will allow Creatd to expand its digital footprint to a global community.

Creatd will partner with a community of technology collaborators and sophisticated investors who collaborate to provide technology solutions for creators, brands and their respective audiences. The company’s solutions, business processes, technology platforms and design theories will lend themselves to application opportunities on a global scale.

History & Management

Jerrick was founded in 2012. Initially a private media company providing online content through a portfolio of brands, Jerrick’s needs quickly outpaced its initial technology and product offering. In 2015, Jerrick partnered with Thinkmill, a premiere, Australia-based product design and development group to create a content management system (CMS) for its brands; that system evolved into the company’s flagship product, Vocal.

Today, Jerrick’s management team is an impressive group of abstract thinkers united by their passion to solve problems. Leading the team are founder and CEO Jeremy Frommer, and Justin Maury, Jerrick’s president and head of product.

Frommer’s career includes two decades in the financial technology industry, working as a hedge fund and portfolio manager, as well as on the sell-side of the financial industry. Frommer started NextGen Trading, a software development company building proprietary equity trading platforms. NextGen was acquired by Carlin Financial Group of which Frommer became CEO. RBC Capital Markets Corporation eventually bought Carlin. At RBC, Frommer was managing director, head of the Global Prime Services group and a member of the RBC Global Equities Operating Committee.

Maury joined Jerrick in 2013, bringing with him 10 years of experience in the creative industry. Since partnering with Frommer to establish Jerrick, Maury led the company’s product development for more than four years. His passion for the creative arts and technology ultimately yielded the vision for Vocal. During the Jerrick’s early formative years, Maury was a driving force in creating the vision, design and architecture for the Vocal platform and managing the oversight of technology development.

Jerrick Media Holdings, Inc. (JMDA), closed Friday's trading session at $3.94, off by 1.50%, on 650 volume with 5 trades. The average volume for the last 3 months is 1,219 and the stock's 52-week low/high is $1.63999998/$5.00.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research ("Zacks SCR") has released an updated research report in its on-going coverage on the Company. Copies of the new Zacks SCR report are available via the following link: http://nnw.fm/8aWe3. To view the full press release, visit http://nnw.fm/M7yQP.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $2.55, off by 0.390625%, on 10,857 volume with 34 trades. The average volume for the last 3 months is 20,254 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX) founder Chris Miglino was featured in a recent LA Weekly Weekly Podcast with Brian Calle to discuss the topic of big data and SRAX’s capabilities in giving power to the individual. “We created a platform that puts the power of the data back in the hands of the consumer,” Miglino said during the podcast, discussing the company’s platform, which currently amasses 17 million users, to assist consumers in monetizing their data. “So, you as a consumer can own all of your own information and get compensated if a marketer tries to access your data. That platform is called BIGtoken.” To listen to the podcast, visit http://nnw.fm/NG2dY.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $2.22, off by 2.2026%, on 18,313 volume with 96 trades. The average volume for the last 3 months is 105,959 and the stock's 52-week low/high is $1.04999995/$5.8499999.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQB: PLPRF), is a branded, cannabis-infused, products manufacturer of edibles created to support a healthy and active lifestyle. PLUS was recently featured in a NetworkNewsAudio interview (http://cnw.fm/r7amH). To view the full article, visit http://cnw.fm/Xp6bM.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday's trading session at $0.9343, off by 1.6526%, on 35,444 volume with 35 trades. The average volume for the last 3 months is 46,933 and the stock's 52-week low/high is $0.839999973/$6.00810003.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings Inc. (OTC: MCTC) was featured today in a publication from HempWireNews, examining how, on Tuesday, Hemp Depot announced that it is making a dramatic shift in the pricing of CBD-rich seeds to increase the economic viability and profitability of hemp farming for U.S. farmers. Hemp Depot is among the largest wholesale providers of the highest quality CBD oil products, seeds, and clones in the United States.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Friday's trading session at $0.35, off by 6.1662%, on 21,990 volume with 12 trades. The average volume for the last 3 months is 16,343 and the stock's 52-week low/high is $0.090000003/$3.00.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) was featured today in the 420 with CNW by CannabisNewsWire. The adult-use marijuana industry in the state of Illinois started on a high note. On Monday, the Department of Financial and Professional Regulation announced that in the month of January, marijuana sales came to a total of $39.2 million.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Friday's trading session at $0.14, off by 9.7357%, on 200 volume with 1 trade. The average volume for the last 3 months is 2,851 and the stock's 52-week low/high is $0.100299999/$0.920000016.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

A growing number of entrepreneurs around the world are turning to direct selling as a way to obtain long-term supplemental income, enjoy flexibility and purchase products at a discount – just a few of the benefits of direct selling, according to the Direct Selling Association (http://nnw.fm/kNuG6). Sharing Services Global Corporation (OTCQB: SHRG), a diversified holding company that focuses on direct selling, is seeing a rising number of individuals join the SHRG ranks as the company offers comprehensive support and a compelling line of products designed to ensure the success of these eager entrepreneurs. Also today, NetworkNewsWire released a report on the company detailing how SHRG is staying ahead of direct-selling market trends, such as integrating operations and activities into a single platform and fighting health problems through research and education. To view the full article, visit http://nnw.fm/YKhz4 .

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.085, off by 9.5745%, on 10,000 volume with 1 trade. The average volume for the last 3 months is 36,765 and the stock's 52-week low/high is $0.065800003/$0.3944.

Recent News

chart

InsuraGuest Inc.

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Inc..

InsuraGuest recently announced the launch of its new wholly owned subsidiary, InsuraGuest Insurance Agency LLC (“IG Agency”). A recent article discussing the company reads, “IG Agency is registered and licensed to sell insurance in 16 states nationwide: Arizona, Arkansas, Colorado, Idaho, Indiana, Iowa, Louisiana, Maryland, Michigan, Montana, Nevada, Ohio, Pennsylvania, South Carolina, Utah and Virginia. To view the full article, visit http://nnw.fm/H1emX.

InsuraGuest Inc. is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.

The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions, as well as plans to expand to Asia in 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United State alone, where there are approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s demographics combined will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Business Highlights

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.

Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Christopher J. Panos Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.


Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that Canopy Rivers Corporation, a wholly owned subsidiary of the company, subscribed for 2,380,952 units of James E. Wagner Cultivation Corp. ("JWC") (TSX.V: JWCA) (OTCQX: JWCAF) at a price of $0.21 each for total consideration of approximately $500,000 in connection with JWC's non-brokered private placement financing. To view the full press release, visit http://cnw.fm/6K4Xr.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Friday's trading session at $0.963, off by 0.608938%, on 173,997 volume with 117 trades. The average volume for the last 3 months is 124,201 and the stock's 52-week low/high is $0.779999971/$3.99.

Recent News

chart

GP Solutions (OTC: GWPD)

The QualityStocks Daily Newsletter would like to spotlight GP Solutions (GWPD).

GP Solutions (OTC: GWPD), the developer of "GrowPods" – controlled environment automated micro-farms, today announced that it is adding to its management team and making changes to its Board of Directors. According to the update, the company appointed Christina Kane as its Director of Sales. Kane has extensive business development experience and global manufacturing expertise, having served as director of a major franchise with over 300 stores and established distribution channels in 40+ countries. To view the full press release, visit http://cnw.fm/5MkQ4.

GP Solutions (OTC: GWPD) is developing scalable farming systems for soil-less indoor organic farming. The company’s GrowPods are automated micro-farms that use hydroponic technology and unique soil systems to cultivate the highest-quality specialty leaf crops. The system is designed and engineered for ease of use, allowing users to farm year-round in any location of the world, supporting the company’s mission to provide customers with the ability to cultivate their own organic “superfoods.”

GrowPod Design & Function

GrowPod is a modular, stackable and mobile vertical growing environment specifically engineered to maximize yield and automation. GrowPods are available as a vertical pod, stacker pod or custom-built pod.

The Stacker Pod is a certified organic soil system that offers growers multiple levels of planting in order to maximize space and produce options with different fruits and vegetables. The Vertical Pod utilizes a vertical hydroponic system. It is affordable, scalable, efficient, automated and sustainable. The output provides customers with fresh and clean produce year-round in any climate. The Custom Pod is built to suit the farmer’s specific crop and grow goals.

Each 320-square-foot GrowPod container will have an annual production capability of up to four times that of outdoor growing methods, dramatically increasing profitability to the grower. The controlled environment of the GrowPod ensures efficient power and water usage in growing a wide range of horticultural and agricultural products in all environments and climates.

Thanks to a combination of hydroponic and certified organic soil systems, crop yields are higher, faster, and more consistent that conventional means. Customers can enjoy an average of eight higher yield crop cycles anywhere in the world.

GrowPod Features:

  • Modular, stackable and mobile
  • Fully insulated, food-grade shipping container
  • Engineered for automation
  • Efficient LED lighting
  • Hydroponic or soil-based platforms
  • Proprietary air and water filtration
  • Climate-controlled
  • Remote monitoring

GP Solutions also offers many services to its customers, including:

  • Shipment and installation service of its shipping container farms
  • On-site training
  • Provision of custom planting and harvesting schedule
  • Provision of growing supplies, seeds, nutrients, packaging, branding and repair materials
  • On-site visits, on-call and scheduled maintenance, and re-supply
  • Remote monitoring and automated control of environmental nutrients, environmental growth factors (PH, temperature, light) and circulation
  • Technical assistance
  • Consulting and custom facility systems design

Competitive Advantage

GrowPods allow cultivation to take place year-round, which maximizes ROI. The systems are sealed from outside pathogens, contaminants, pesticides, and the result is clean and robust crop production.

GP Solutions also has a line of remarkable new proprietary soil mixtures and nutrient lines which contain no animal products. These products are vital, as many other soils and additives can contain harmful pathogens and contaminants that can cause crops to become tainted or fail rigorous testing.

Global Solution

GP Solutions has partnered with the world’s leading food nonprofit companies, including Feeding America, Seeds of Hope, Habitat for Humanity, Meals on Wheels America, L.A. Kitchen, and Farm Bread, to help insecure communities take control of their own food dependence using container farms.

GP Solutions (GWPD), closed Friday's trading session at $0.61, even for the day, on 260 volume. The average volume for the last 3 months is 1,152 and the stock's 52-week low/high is $0.600000023/$21.00.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing The Supreme Cannabis Company's (TSX: FIRE) (OTCQX: SPRWF) approach on premium cultivation at scale, growth with a higher purpose. Supreme Cannabis recently completed (as of December 21, 2019) all major construction of its 7ACRES cultivation facility. The project that started in May 2017 was actually a rebuild of a former tomato greenhouse in Kincardine, Ontario. The final product was a state-of-the-art, 440,000 square foot facility that produces premium cannabis for the company's 7ACRES brand.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.3445, off by 6.3566%, on 643,534 volume with 304 trades. The average volume for the last 3 months is 493,525 and the stock's 52-week low/high is $0.330000013/$1.75.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $2.55, off by 0.390625%, on 10,857 volume with 34 trades. The average volume for the last 3 months is 20,254 and the stock's 52-week low/high is $0.600600004/$4.0300002.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.